GLP-1 drugs such as Novo Nordisk's Ozempic can cut drug and alcohol abuse by around half. Meanwhile, tech companies are ...

Wider access to weight-loss medications could save 40,000 lives each year in the U.S., but costs and insurance limits are ...

A new study suggests weight loss drugs like Ozempic and Mounjaro could provide a promising new treatment for substance use ...

Weight-loss drugs have skyrocketed in popularity because of their quick results and use among celebrities and influencers. J.P. Morgan predicts that by 2030, 30 million Americans will use them.

A staggering 64% of adults in England are classed as either overweight or obese according to the most recent NHS figures. And ...

Expanding access to new, highly effective weight-loss medications could prevent more than 40,000 deaths a year in the United States, according to a study. The findings highlight the critical need to ...

Ozempic maker Novo Nordisk (NVO) is asking the U.S. Food and Drug Administration (FDA) to prohibit compounding pharmacies ...

Weight-loss surgery reduces worklessness, data from the Office for National Statistics has suggested. It found patients who ...

Disclaimer: This is non-editorial content, and ETHealthworld,TIL does not guarantee, vouch for, or endorse any of it. This ...

Despite the benefits of such medicines, like Wegovy, Saxenda and Zepbound, many people who could most benefit from them can’t ...

Most U.S. states do not currently cover highly sought-after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...